Sunil Healthcare FY26 consolidated profit rises, standalone loss reported
Sunil Healthcare Limited reported a consolidated net profit of ₹400.60 lakh for FY26, against a consolidated loss of ₹141.66 lakh in the previous year, while standalone results reflected a net loss of ₹530.21 lakh. The standalone loss was driven by exceptional items of ₹958.25 lakh, including a ₹946.66 lakh provision for a foreign subsidiary and a ₹355.95 lakh write-off for a fire incident at the Alwar plant. The Board approved the audited results on May 29, 2026, and the company published the financial results in newspapers on May 31, 2026.

*this image is generated using AI for illustrative purposes only.
Sunil Healthcare Limited reported a consolidated net profit of ₹400.60 lakh for the financial year ended March 31, 2026, while its standalone results reflected a net loss of ₹530.21 lakh. The standalone performance was significantly impacted by exceptional items amounting to ₹958.25 lakh, primarily due to a provision for a foreign subsidiary and a fire incident at its Alwar plant. The company published the audited financial results for the quarter and year ended March 31, 2026, in the newspaper Pioneer on May 31, 2026, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company's consolidated revenue from operations for FY26 stood at ₹8,990.15 lakh, compared to ₹8,476.02 lakh in the previous year. On a standalone basis, revenue increased to ₹8,886.23 lakh from ₹8,477.28 lakh in FY25. The statutory auditors, M/s. Singhi & Co., Chartered Accountants, issued an unmodified opinion on the annual standalone and consolidated financial results.
Financial Performance
The divergence between standalone and consolidated profitability was driven by exceptional items recorded during the quarter ended March 31, 2026. The company reassessed the recoverability of outstanding balances from a foreign subsidiary, leading to a provision of ₹946.66 lakh. Additionally, a fire incident at the Alwar manufacturing plant resulted in damage to property, plant, and equipment with a carrying value of ₹355.95 lakh, which was written off. The company has recognized an insurance claim receivable of ₹344.35 lakh, expecting the loss to be fully recoverable.
| Metric | Standalone FY26 (₹ in Lakhs) | Standalone FY25 (₹ in Lakhs) | Consolidated FY26 (₹ in Lakhs) | Consolidated FY25 (₹ in Lakhs) |
|---|---|---|---|---|
| Revenue from Operations | 8,886.23 | 8,477.28 | 8,990.15 | 8,476.02 |
| Total Income | 8,886.23 | 8,477.28 | 8,990.15 | 8,476.02 |
| Total Expenses | 8,635.79 | 8,436.68 | 8,755.56 | 8,597.59 |
| Profit/(Loss) for the period | (530.21) | 20.51 | 400.60 | (141.66) |
Board Decisions
The Board of Directors met on May 29, 2026, to discuss the financial outcomes. In addition to approving the audited financial results, the Board appointed M/s. Agrawal S. Lal & Co., Chartered Accountants, as internal auditors for the financial year 2026-27. The Board also approved the Directors' Report for FY26.
The company's total assets as of March 31, 2026, stood at ₹16,232.00 lakh on a standalone basis and ₹16,450.55 lakh on a consolidated basis. The cash and cash equivalents at the end of the year were ₹6.53 lakh for the standalone entity and ₹7.39 lakh for the consolidated entity.
Historical Stock Returns for Sunil Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.97% | -3.05% | -1.87% | -13.07% | -14.22% | +98.74% |
What is the expected timeline for the settlement of the ₹344.35 lakh insurance claim regarding the Alwar plant fire?
How does the company plan to address the recoverability issues with the foreign subsidiary to prevent future provisions?
Will the fire incident at the Alwar plant impact production capacity or revenue growth in the upcoming fiscal year?






























